These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28734596)

  • 1. Developments in urologic oncology «OncoForum»: The best of 2016.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo JM
    Actas Urol Esp; 2017 Nov; 41(9):543-551. PubMed ID: 28734596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments in urologic oncology "OncoForum": The best of 2017.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp (Engl Ed); 2018 Oct; 42(8):488-498. PubMed ID: 29935800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in urologic oncology "OncoForum": The best of 2019.
    Gómez-Veiga F; Alcaraz Asensio A; Burgos Revilla J; Cózar Olmo J
    Actas Urol Esp (Engl Ed); 2020 Nov; 44(9):586-596. PubMed ID: 32948345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developments in urologic oncology «OncoForum»: The best of 2015.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp; 2016; 40(6):361-9. PubMed ID: 27061663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in uro-oncology "OncoForum": the best of 2013.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp; 2014 Oct; 38(8):491-8. PubMed ID: 24731526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in uro-oncology «Oncoforum»: the best of 2011].
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp; 2012 Oct; 36(9):507-14. PubMed ID: 22520042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developments in urologic oncology 'OncoForum': The best of 2014.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp; 2015 Jun; 39(5):271-8. PubMed ID: 25770399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in urologic oncology "OncoUrology Forum Special Edition": The best of 2020.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla JM; Cózar-Olmo FJ
    Actas Urol Esp (Engl Ed); 2022 May; 46(4):214-222. PubMed ID: 34844900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study.
    Shore ND; Chowdhury S; Villers A; Klotz L; Siemens DR; Phung D; van Os S; Hasabou N; Wang F; Bhattacharya S; Heidenreich A
    Lancet Oncol; 2016 Feb; 17(2):153-163. PubMed ID: 26774508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Enzalutamide vs Bicalutamide in Younger and Older Patients with Metastatic Castration Resistant Prostate Cancer in the TERRAIN Trial.
    Siemens DR; Klotz L; Heidenreich A; Chowdhury S; Villers A; Baron B; van Os S; Hasabou N; Wang F; Lin P; Shore ND
    J Urol; 2018 Jan; 199(1):147-154. PubMed ID: 28827103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.
    Cornford P; Bellmunt J; Bolla M; Briers E; De Santis M; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; van der Poel HG; van der Kwast TH; Rouvière O; Wiegel T; Mottet N
    Eur Urol; 2017 Apr; 71(4):630-642. PubMed ID: 27591931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Update urooncology: news with clinical relevance from major scientific meetings 2012].
    Hegele A; Skrobek L; Schrader AJ
    Aktuelle Urol; 2012 Dec; 43(6):376-87. PubMed ID: 23254351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Enzalutamide Compared with Bicalutamide on Quality of Life in Men with Metastatic Castration-resistant Prostate Cancer: Additional Analyses from the TERRAIN Randomised Clinical Trial.
    Heidenreich A; Chowdhury S; Klotz L; Siemens DR; Villers A; Ivanescu C; Holmstrom S; Baron B; Wang F; Lin P; Shore ND
    Eur Urol; 2017 Apr; 71(4):534-542. PubMed ID: 27497762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urologic malignancies in renal transplant candidates and recipients].
    Kleinclauss F; Thuret R; Murez T; Timsit MO
    Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urologic cancer in Indonesia.
    Umbas R; Safriadi F; Mochtar CA; Djatisoesanto W; Hamid AR
    Jpn J Clin Oncol; 2015 Aug; 45(8):708-12. PubMed ID: 26085688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [News with clinical relevance from major scientific meetings 2014 - Update Urooncology].
    Hegele A; Skrobek L; Boegemann M
    Aktuelle Urol; 2015 Mar; 46(2):106-17. PubMed ID: 25909966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial.
    Penson DF; Armstrong AJ; Concepcion R; Agarwal N; Olsson C; Karsh L; Dunshee C; Wang F; Wu K; Krivoshik A; Phung D; Higano CS
    J Clin Oncol; 2016 Jun; 34(18):2098-106. PubMed ID: 26811535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study.
    Fizazi K; Kramer G; Eymard JC; Sternberg CN; de Bono J; Castellano D; Tombal B; Wülfing C; Liontos M; Carles J; Iacovelli R; Melichar B; Sverrisdóttir Á; Theodore C; Feyerabend S; Helissey C; Oudard S; Facchini G; Poole EM; Ozatilgan A; Geffriaud-Ricouard C; Bensfia S; de Wit R
    Lancet Oncol; 2020 Nov; 21(11):1513-1525. PubMed ID: 32926841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urologic cancer in China.
    Pang C; Guan Y; Li H; Chen W; Zhu G
    Jpn J Clin Oncol; 2016 Jun; 46(6):497-501. PubMed ID: 27049022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.